🇺🇸 Tenofovir Alafenamide Fumarate tablets in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alanine Aminotransferase Increased — 1 report (10%)
  2. Anaemia — 1 report (10%)
  3. Aspartate Aminotransferase Increased — 1 report (10%)
  4. Bile Acids Increased — 1 report (10%)
  5. Erythema — 1 report (10%)
  6. Folliculitis — 1 report (10%)
  7. Gamma-Glutamyltransferase Increased — 1 report (10%)
  8. Hyperglycaemia — 1 report (10%)
  9. Hypoalbuminaemia — 1 report (10%)
  10. Hypocalcaemia — 1 report (10%)

Source database →

Tenofovir Alafenamide Fumarate tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Tenofovir Alafenamide Fumarate tablets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Tenofovir Alafenamide Fumarate tablets in United States?

Southeast University, China is the originator. The local marketing authorisation holder may differ — check the official source linked above.